Dianthus Therapeutics, Inc.
Pharmaceutical Preparations · New York, NY, United States
- PrincipalsEdward CarrCHIEF ACCOUNTING OFFICERMarino GarciaCEO AND PRESIDENTRyan SavitzCFO & CBOand 3 more
- CompanyDianthus Therapeutics, Inc.New York, NY, United States
- Phone line+1 (929) 999-4055General business
Dianthus Therapeutics, Inc. /DE/ is an SEC-registered Nasdaq-listed company (ticker DNTH) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chief executive
Marino GarciaCEO AND PRESIDENT
Chair & board
Paula SoteropoulosDirector (Board)
Technology & engineering
Simrat RandhawaEVP, Head of R&D
Legal
Adam M VenessSVP, General Counsel and Sec.
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Edward Carr — CHIEF ACCOUNTING OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Adam M Veness — SVP, General Counsel and Sec.
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Ryan Savitz — CFO & CBO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Marino Garcia — CEO AND PRESIDENT
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capability